(Q82879823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

squamous cell carcinoma

1 reference

3

Lester J Layfield

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Carlynn Willmore-Payne

series ordinal

1

object named as

Carlynn Willmore-Payne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Joseph A Holden

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

634-640

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16547470%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.3800552

18 January 2020

exact match

0 references

cites work

Switching on kinases: oncogenic activation of BRAF and the PDGFR family

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Biology of gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Lung cancer: intragenic ERBB2 kinase mutations in tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Medical treatment in head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

The role of cetuximab in the treatment of squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Selecting patients for epidermal growth factor receptor inhibitor treatment: A FISH story or a tale of mutations?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021

Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800552

7 January 2021